(Those were the days!) In 1966, Blue Cross Blue Shield companies were the only insurers who had the claims processing capability and computing power to administer the new Medicare program
Habener and colleagues demonstrated that GLP1 augmentation could be used to treat type 2 diabetes, laying the scientific foundation for the GLP1based therapies now widely used to improve glycemic control, promote weight loss, and reduce cardiovascular events
This combination targets gastrointestinal inflammation, crucial for maintaining gut function and influencing ot
doi:10.1159/000116143 Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D
Jul 1 2023;11(7)doi:10.3390/biomedicines11071875 FDA
Other Ingredients:Hypromellose (cellulose capsule), Rice Flour, Stearic Acid (vegetable source) and Silicon Dioxide